We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Showcases Innovative Diagnostic and Biopharma Solutions

By LabMedica International staff writers
Posted on 26 Jul 2023

Fapon Biotech (Guangdong, China) is presenting its latest innovations in in-vitro diagnostic and biopharma solutions at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo. More...

At AACC 2023, Fapon is introducing its latest chemiluminescence immunoassay (CLIA) system, the Shine i8000/9000. This ultra-high throughput, fully automated analyzer delivers initial results within 10 minutes at a rate of 900 tests per hour. The system's high throughput per footprint, delivering 377 tests/hour/m2, makes it an ideal choice for labs seeking to boost their testing capacity and efficiency. The launch of the Shine i8000/9000 further expands the company's extensive portfolio of high, medium, and low-throughput chemiluminescence analyzers. Fapon continues to integrate its one-stop solution on CLIA raw materials, reagents, and open instruments services to further innovate clinical diagnostic solutions for its IVD partners.

With a 22-year background in IVD raw materials, Fapon is presenting its extensive core IVD raw materials solutions for immunoassay and PCR & LAMP. At AACC 2023, the company is spotlighting its high-quality respiratory raw materials designed to expedite the development of rapid tests for SARS-CoV-2, Influenza A/B and RSV antigen-based multi-analyte tests. These materials offer authoritative panel validation, superior sensitivity, and affordable, high-quality supply. Also, the company is introducing its qPCR lyophilized master mix, featuring high activity before and after lyophilization, robust stability, quick solubilized cakes/beads, and customizable solutions and lyophilization service.

Fapon is also highlighting its groundbreaking solution for drug discovery and development. Fapon Biopharma, its subsidiary, has developed a fully-integrated platform for novel biological products, comprising programs from the discovery to clinical research stages. The company's antibody platform specializes in developing and manufacturing innovative antibodies and fusion proteins. Fapon excels in antibody discovery, bispecific antibodies, antibody-cytokine fusion proteins, and PROTiNB. The development of FP002, a superior anti-tumor efficacy and high-reliability anti-CD47 drug, demonstrates Fapon's comprehensive capabilities from early discovery, CMC, preclinical studies to clinical registration. The cell therapy platform focuses on universal and next-generation CAR-T cell therapies for solid tumors, with their flagship product FC001 targeting CD19.

As the global leader in circular RNA technology, Fapon continues to address the technical bottlenecks of circRNA industrialization and demonstrate its competitive advantage in the industry through various cooperative models. At AACC 2023, Fapon is also delivering an interactive lecture titled "Bioanalytical Performance of Novel Protein-free Blockers & Heterophilic Antibody Interference Blockers for the IVD Industry & Clinical Diagnostics," offering insights into the latest advancements in IVD blockers.

"We are thrilled to be showcasing our latest solutions and offerings at the 2023 AACC Expo," said Jielun ZHU, CFO & CIO of Fapon. "Fapon is committed in becoming a global leading provider of fundamental technological solutions for diagnosis and biotherapy. We aim to establish a global open ecosystem with our partners to develop cutting-edge diagnostic and biopharma solutions that can address diverse needs in healthcare."

Related Links:
Fapon Biotech 


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources (Photo courtesy of Tagomics)

Highly Sensitive and Specific Test to Enable Early Detection of Colorectal Cancer

A highly sensitive and specific diagnostic test for the early detection and treatment of colorectal cancer could enable treatment at the earliest possible stages of disease development. Tagomics Ltd.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The LIAISON PLEX® Gram-Positive Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection

Each year, around 250,000 individuals in the US are diagnosed with bloodstream infections (BSIs). Sepsis caused by these infections carries a mortality rate ranging from 16% to 40%, and any delay in administering... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.